Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 24.21
(-0.62%)
INR 24.21
(-0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 446.09 Million | 783.88 Million | 853.33 Million | 668.36 Million | 836.45 Million | 347.98 Million |
| Cost of Revenue | 592.76 Million | 660.46 Million | 883.49 Million | 619.21 Million | 796.87 Million | 299.06 Million |
| Gross Profit | -146.67 Million | 123.41 Million | -30.16 Million | 49.15 Million | 39.57 Million | 48.91 Million |
| Operating Expenses | 184.08 Million | 171.95 Million | 180.82 Million | 154.39 Million | 133.71 Million | 132.33 Million |
| Selling, General and Administrative Expenses | 9.88 Million | 6.5 Million | 7.04 Million | 7.29 Million | 8.37 Million | 4.72 Million |
| Research and Development Expenses | - | 5000.00 | 4.8 Million | 5.22 Million | 5.79 Million | - |
| Other Expenses | 14.12 Million | 234 Thousand | 256 Thousand | 368 Thousand | 564 Thousand | 278 Thousand |
| Cost and Expenses | 606.16 Million | 832.41 Million | 1.06 Billion | 773.6 Million | 930.59 Million | 431.4 Million |
| Operating Income | -160.07 Million | -48.64 Million | -211.19 Million | -106.03 Million | -95.94 Million | -85.32 Million |
| Interest Expense | 70.41 Million | 51.08 Million | 43.63 Million | 40.62 Million | 14.57 Million | 8.25 Million |
| Income Tax Expense | -57.94 Million | -9.33 Million | -60.95 Million | -39.91 Million | -15.8 Million | -36.97 Million |
| Earnings before Tax | -222.67 Million | -96.87 Million | -242.07 Million | -142.03 Million | -73.73 Million | -79.58 Million |
| Net Income | -166.38 Million | -87.53 Million | -181.12 Million | -102.11 Million | -57.93 Million | -42.61 Million |
| Earnings Per Share Basic | -3.85 | -2.03 | -4.19 | -2.36 | -1.34 | -0.99 |
| Earnings Per Share Diluted | -3.85 | -2.03 | -4.19 | -2.36 | -1.34 | -0.99 |
| Weighted Average Shares Outstanding | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million | 43.18 Million |
| Gross Margin | -0.33 | 0.16 | -0.04 | 0.07 | 0.05 | 0.14 |
| EBIT Margin | -0.34 | -0.05 | -0.24 | -0.15 | -0.07 | -0.20 |
| Profit Margin | -0.37 | -0.11 | -0.21 | -0.15 | -0.07 | -0.12 |
| EBITDA | -151.05 Million | -38.83 Million | -191.93 Million | -92.24 Million | -50.93 Million | -67.25 Million |
| Earnings Before Tax Margin | -0.36 | -0.06 | -0.25 | -0.16 | -0.11 | -0.25 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 76.5 Million | 446.09 Million | - | 264.79 Million |
| Cost of Revenue | 343 Thousand | 26 Thousand | 110.64 Million | 422.08 Million | -13.24 Million | 243.79 Million |
| Gross Profit | -343 Thousand | -26 Thousand | -34.14 Million | 24 Million | 13.24 Million | 21 Million |
| Operating Expenses | 47.22 Million | 43.5 Million | 62.95 Million | 184.08 Million | 41.36 Million | 46.37 Million |
| Selling, General and Administrative Expenses | 46.88 Million | 43.13 Million | 33.14 Million | - | 19.5 Million | 6.5 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.63 Million | 1.01 Million | 54.25 Million | 1.22 Million | -18.48 Million | 3.19 Million |
| Cost and Expenses | 47.22 Million | 43.53 Million | 173.59 Million | 606.16 Million | 28.12 Million | 290.16 Million |
| Operating Income | -47.22 Million | -43.48 Million | 42.99 Million | -161.46 Million | -47.63 Million | -25.36 Million |
| Interest Expense | 20.87 Million | 17.21 Million | 19.71 Million | 69.62 Million | 16.68 Million | 17.42 Million |
| Income Tax Expense | -17.28 Million | -13.8 Million | -18 Million | -56.29 Million | -16.45 Million | -8.76 Million |
| Earnings before Tax | -66.46 Million | -59.67 Million | -56.75 Million | -222.67 Million | -63.29 Million | -39.59 Million |
| Net Income | -49.18 Million | -45.87 Million | -38.75 Million | -166.38 Million | -46.83 Million | -30.83 Million |
| Earnings Per Share Basic | -1.14 | -1.06 | -0.99 | - | -1.08 | -0.71 |
| Earnings Per Share Diluted | -1.14 | -1.06 | -0.99 | - | -1.08 | -0.71 |
| Weighted Average Shares Outstanding | 43.18 Million | 43.18 Million | - | 43.18 Million | 43.18 Million | 43.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.18 Million | 43.18 Million | - | 43.18 Million | 43.18 Million | 43.42 Million |
| Gross Margin | - | - | -0.45 | 0.05 | - | 0.08 |
| EBIT Margin | - | - | -0.47 | - | - | -0.08 |
| Profit Margin | - | - | -0.51 | -0.37 | - | -0.12 |
| EBITDA | -45.24 Million | -42.12 Million | -36.13 Million | - | -46.24 Million | -21.8 Million |
| Earnings Before Tax Margin | - | - | 0.56 | -0.36 | - | -0.10 |
MITSU
PFMT
PAYO
9068
ENB-PT
SHIP